{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:12Z","timestamp":1784867052136,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00213-009-1484-9","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T10:43:46Z","timestamp":1235472226000},"page":"575-585","source":"Crossref","is-referenced-by-count":33,"title":["Modeling \u201cpsychosis\u201d in vitro by inducing disordered neuronal network activity in cortical brain slices"],"prefix":"10.1007","volume":"206","author":[{"given":"George K.","family":"Aghajanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,25]]},"reference":[{"key":"1484_CR1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-8993(00)02298-8","volume":"867","author":"T Abekawa","year":"2000","unstructured":"Abekawa T, Ohmori T, Ito K, Koyama T (2000) D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex. Brain Res 867:250\u20134","journal-title":"Brain Res"},{"key":"1484_CR2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1073858403252674","volume":"9","author":"A Abi-Dargham","year":"2003","unstructured":"Abi-Dargham A, Moore H (2003) Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9:404\u201316","journal-title":"Neuroscientist"},{"key":"1484_CR3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0028-3908(97)00051-8","volume":"36","author":"GK Aghajanian","year":"1997","unstructured":"Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589\u2013599","journal-title":"Neuropharmacology"},{"key":"1484_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","volume":"825","author":"GK Aghajanian","year":"1999","unstructured":"Aghajanian GK, Marek GJ (1999) Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res 825:161\u2013171","journal-title":"Brain Res"},{"key":"1484_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","volume":"31","author":"GK Aghajanian","year":"2000","unstructured":"Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Rev 31:302\u2013312","journal-title":"Brain Res Rev"},{"key":"1484_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","volume":"52","author":"S Akbarian","year":"1995","unstructured":"Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258\u2013266","journal-title":"Arch Gen Psychiatry"},{"key":"1484_CR7","doi-asserted-by":"crossref","first-page":"9985","DOI":"10.1073\/pnas.93.18.9985","volume":"93","author":"NC Andreasen","year":"1996","unstructured":"Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Ponto LL, Watkins GL, Hichwa RD (1996) Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal\u2013thalamic\u2013cerebellar circuitry. Proc Natl Acad Sci U S A 93:9985\u20139990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1484_CR8","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1152\/jn.00898.2006","volume":"97","author":"S Bandyopadhyay","year":"2007","unstructured":"Bandyopadhyay S, Hablitz JJ (2007) Dopaminergic modulation of local network activity in rat prefrontal cortex. J Neurophysiol 97:4120\u20134128","journal-title":"J Neurophysiol"},{"key":"1484_CR9","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.1523\/JNEUROSCI.22-22-09885.2002","volume":"22","author":"M Beierlein","year":"2002","unstructured":"Beierlein M, Fall CP, Rinzel J, Yuste R (2002) Thalamocortical bursts trigger recurrent activity in neocortical networks: layer 4 as a frequency-dependent gate. J Neurosci 22:9885\u20139894","journal-title":"J Neurosci"},{"key":"1484_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","volume":"25","author":"FM Benes","year":"2001","unstructured":"Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1\u201327","journal-title":"Neuropsychopharmacology"},{"key":"1484_CR11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.107.035170","volume":"72","author":"MA Benneyworth","year":"2007","unstructured":"Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, Sanders-Bush E (2007) A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Mol Pharmacol 72:477\u2013484","journal-title":"Mol Pharmacol"},{"key":"1484_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0006-8993(98)01243-8","volume":"816","author":"JP Charton","year":"1999","unstructured":"Charton JP, Herkert M, Becker CM, Schroder H (1999) Cellular and subcellular localization of the 2B-subunit of the NMDA receptor in the adult rat telencephalon. Brain Res 816:609\u2013617","journal-title":"Brain Res"},{"key":"1484_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","volume":"37","author":"PJ Conn","year":"1997","unstructured":"Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205\u2013237","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1484_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(97)00071-1","volume":"82","author":"P Danos","year":"1998","unstructured":"Danos P, Baumann B, Bernstein HG, Franz M, Stauch R, Northoff G, Krell D, Falkai P, Bogerts B (1998) Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res 82:1\u201310","journal-title":"Psychiatry Res"},{"key":"1484_CR15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02246070","volume":"121","author":"R Beaurepaire de","year":"1995","unstructured":"de Beaurepaire R, Labelle A, Naber D, Jones BD, Barnes TR (1995) An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states. Psychopharmacology (Berl) 121:323\u2013327","journal-title":"Psychopharmacology (Berl)"},{"key":"1484_CR16","first-page":"123","volume":"2","author":"T Paulis de","year":"2001","unstructured":"de Paulis T (2001) M-100907 (Aventis). Curr Opin Investig Drugs 2:123\u201332","journal-title":"Curr Opin Investig Drugs"},{"key":"1484_CR17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.108.136861","volume":"326","author":"MJ Fell","year":"2008","unstructured":"Fell MJ, Svensson KA, Johnson BG, Schoepp DD (2008) Evidence for the Role of metabotropic glutamate (mGlu) 2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2\/3 receptor agonist (\u2013)-(1R, 4S, 5S, 6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4, 6-dicarboxylic acid (LY404039). J Pharmacol Ex Ther 326:209\u2013217","journal-title":"J Pharmacol Ex Ther"},{"key":"1484_CR18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuron.2004.08.011","volume":"43","author":"T Fellin","year":"2004","unstructured":"Fellin T, Pascual O, Gobbo S, Pozzan T, Haydon PG, Carmignoto G (2004) Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43:729\u2013743","journal-title":"Neuron"},{"key":"1484_CR19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/schbul\/sbm062","volume":"33","author":"JM Ford","year":"2007","unstructured":"Ford JM, Krystal JH, Mathalon DH (2007) Neural synchrony in schizophrenia: from networks to new treatments. Schizophrenia Bulletin Schizophr Bull 33:848\u2013852","journal-title":"Schizophrenia Bulletin Schizophr Bull"},{"key":"1484_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1073\/pnas.98.1.295","volume":"98","author":"WJ Gao","year":"2001","unstructured":"Gao WJ, Krimer LS, Goldman-Rakic PS (2001) Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci U S A 98:295\u2013300","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1484_CR21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.schres.2007.03.011","volume":"93","author":"MS George","year":"2007","unstructured":"George MS, Molnar CE, Grenesko EL, Anderson B, Mu Q, Johnson K, Nahas Z, Knable Z, Fernandes P, Juncos J, Huang X, Nichols D, Mailman RB (2007) A single 20\u00a0mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophrenia Research 93:42\u201350","journal-title":"Schizophrenia Research"},{"key":"1484_CR22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","volume":"452","author":"J Gonzalez-Maeso","year":"2008","unstructured":"Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, Lopez-Gimenez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC (2008) Identification of a serotonin\/glutamate receptor complex implicated in psychosis. Nature 452:93\u201397","journal-title":"Nature"},{"key":"1484_CR23","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1152\/jn.00335.2002","volume":"88","author":"N Gorelova","year":"2002","unstructured":"Gorelova N, Seamans JK, Yang CR (2002) Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol 88:3150\u201366","journal-title":"J Neurophysiol"},{"key":"1484_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2005-916185","volume":"38","author":"E Gouzoulis-Mayfrank","year":"2005","unstructured":"Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar K-A (2005) Psychological effects of (S)-ketamine and N, N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Pharmacopsychiatry 38:301\u2013311","journal-title":"Pharmacopsychiatry"},{"key":"1484_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(00)26003-2","volume":"126","author":"HJ Groenewegen","year":"2000","unstructured":"Groenewegen HJ, Uylings HB (2000) The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 126:3\u201328","journal-title":"Prog Brain Res"},{"key":"1484_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","volume":"180","author":"A Guidotti","year":"2005","unstructured":"Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E (2005) GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) 180:191\u2013205","journal-title":"Psychopharmacology (Berl)"},{"key":"1484_CR27","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1523\/JNEUROSCI.5297-05.2006","volume":"26","author":"B Haider","year":"2006","unstructured":"Haider B, Duque A, Hasenstaub AR, McCormick DA (2006) Neocortical network activity in vivo is generated through a dynamic balance of excitation and inhibition. J Neurosci 26:4535\u20134545","journal-title":"J Neurosci"},{"key":"1484_CR28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2004.05.027","volume":"1017","author":"M Harte","year":"2004","unstructured":"Harte M, O\u2019Connor WT (2004) Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat. Brain Res 1017:120\u2013129","journal-title":"Brain Res"},{"key":"1484_CR29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-005-2203-9","volume":"179","author":"GA Higgins","year":"2005","unstructured":"Higgins GA, Ballard TM, Enderlin M, Haman M, Kemp JA (2005) Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat. Psychopharmacology (Berl) 179:85\u201398","journal-title":"Psychopharmacology (Berl)"},{"key":"1484_CR30","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","volume":"27","author":"H Homayoun","year":"2007","unstructured":"Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27:11496\u201311500","journal-title":"J Neurosci"},{"key":"1484_CR31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1152\/physrev.00049.2005","volume":"86","author":"PG Haydon","year":"2006","unstructured":"Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86:1009\u20131031","journal-title":"Physiol Rev"},{"key":"1484_CR32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","volume":"156","author":"S Kapur","year":"1999","unstructured":"Kapur S, Zipursky RB, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156:286\u2013293","journal-title":"Am J Psychiatry"},{"key":"1484_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP et al (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuro-endocrine responses. Arch Gen Psychiatry 51:199\u2013214","journal-title":"Arch Gen Psychiatry"},{"key":"1484_CR34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0896-6273(03)00598-1","volume":"40","author":"E Lambe","year":"2003","unstructured":"Lambe E, Aghajanian G (2003) Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40:139\u2013150","journal-title":"Neuron"},{"key":"1484_CR35","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/sj.npp.1300944","volume":"31","author":"EK Lambe","year":"2006","unstructured":"Lambe EK, Aghajanian GK (2006) Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: role of glutamate spillover and NR2B-NMDA receptors. Neuropsychopharmacology 31:1682\u20131689","journal-title":"Neuropsychopharmacology"},{"key":"1484_CR36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neuroscience.2006.12.048","volume":"145","author":"EK Lambe","year":"2007","unstructured":"Lambe EK, Aghajanian GK (2007) Prefrontal cortical network activity: opposite effects of psychedelic hallucinogens and D1\/D5 dopamine receptor activation. Neuroscience 145:900\u2013910","journal-title":"Neuroscience"},{"key":"1484_CR37","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1523\/JNEUROSCI.0719-05.2005","volume":"25","author":"EK Lambe","year":"2005","unstructured":"Lambe EK, Olausson P, Horst NK, Taylor JR, Aghajanian GK (2005) Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J Neurosci 25:5225\u20135229","journal-title":"J Neurosci"},{"key":"1484_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.schres.2006.05.002","volume":"87","author":"DJ Lang","year":"2006","unstructured":"Lang DJ, Khorram B, Goghari VM, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Honer WG (2006) Reduced anterior internal capsule and thalamic volumes in first-episode psychosis. Schizophr Res 87:89\u201399","journal-title":"Schizophr Res"},{"key":"1484_CR39","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1176\/appi.ajp.158.9.1411","volume":"158","author":"DA Lewis","year":"2001","unstructured":"Lewis DA, Cruz DA, Melchitzky DS, Pierri JN (2001) Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry 158:1411\u20131422","journal-title":"Am J Psychiatry"},{"key":"1484_CR40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","volume":"6","author":"DA Lewis","year":"2005","unstructured":"Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312\u201324","journal-title":"Nat Rev Neurosci"},{"key":"1484_CR41","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2008.08030395","volume":"165","author":"DA Lewis","year":"2008","unstructured":"Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, Montrose D (2008) Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry 165:1585\u20131593","journal-title":"Am J Psychiatry"},{"key":"1484_CR42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(90)90353-B","volume":"111","author":"HJ Luhmann","year":"1990","unstructured":"Luhmann HJ, Prince DA (1990) Transient expression of polysynaptic NMDA receptor-mediated activity during neocortical development. Neurosci Lett 111:109\u2013115","journal-title":"Neurosci Lett"},{"key":"1484_CR43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1461145705005328","volume":"8","author":"MM Marcus","year":"2005","unstructured":"Marcus MM, Jardemark KE, Wadenberg ML, Langlois X, Hertel P, Svensson TH (2005) Combined alpha2 and D2\/3 receptor blockade enhances cortical glutamatergic transmission and reverses cognitive impairment in the rat. Int J Neuropsychopharmacol 8:315\u2013327","journal-title":"Int J Neuropsychopharmacol"},{"key":"1484_CR44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(24)35262-0","volume":"292","author":"GJ Marek","year":"2000","unstructured":"Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK (2000) Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76\u20138","journal-title":"J Pharmacol Exp Ther"},{"key":"1484_CR45","doi-asserted-by":"crossref","first-page":"R294","DOI":"10.1016\/j.cub.2005.04.009","volume":"15","author":"DA McCormick","year":"2005","unstructured":"McCormick DA (2005) Neuronal networks: flip-flops in the brain. Curr Biol 15:R294\u2013R296","journal-title":"Curr Biol"},{"key":"1484_CR46","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cercor\/bhg104","volume":"13","author":"DA McCormick","year":"2003","unstructured":"McCormick DA, Shu Y, Hasenstaub A, Sanchez-Vives M, Badoual M, Bal T (2003) Persistent cortical activity: mechanisms of generation and effects on neuronal excitability. Cereb Cortex 13:1219\u201331","journal-title":"Cereb Cortex"},{"key":"1484_CR47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1999.tb07979.x","volume":"890","author":"RE Merchant","year":"1999","unstructured":"Merchant RE, Bullock MR, Carmack CA, Shah AK, Wilner KD, Ko G et al (1999) A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101, 606 in patients with a mild or moderate traumatic brain injury. Ann NY Acad Sci 890:42\u201350","journal-title":"Ann NY Acad Sci"},{"key":"1484_CR48","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","volume":"281","author":"B Moghaddam","year":"1998","unstructured":"Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349\u20131352","journal-title":"Science"},{"key":"1484_CR49","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"1484_CR50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.brainres.2004.07.044","volume":"1023","author":"JW Muschamp","year":"2004","unstructured":"Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA (2004) Lysergic acid diethylamide and [ ]-2, 5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res 1023:134\u2013140","journal-title":"Brain Res"},{"key":"1484_CR51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","volume":"13","author":"ST Patil","year":"2007","unstructured":"Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD (2007) Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a andomized Phase 2 clinical trial. Nat Med 13:1102\u20131107","journal-title":"Nat Med"},{"key":"1484_CR52","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1073\/pnas.2235811100","volume":"100","author":"CC Petersen","year":"2003","unstructured":"Petersen CC, Hahn TT, Mehta M, Grinvald A, Sakmann B (2003) Interaction of sensory responses with spontaneous depolarization in layer 2 \u2044 3 barrel cortex. Proc Natl Acad Sci U S A 100:13638\u201313643","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1484_CR53","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(97)00339-9","volume":"43","author":"CM Portas","year":"1998","unstructured":"Portas CM, Goldstein JM, Shenton ME, Hokama HH, Wible CG, Fischer I, Kikinis R, Donnino R, Jolesz FA, McCarley RW (1998) Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 43:649\u2013659","journal-title":"Biol Psychiatry"},{"key":"1484_CR54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0920-9964(02)00339-0","volume":"57","author":"G Rajkowska","year":"2002","unstructured":"Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C (2002) Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57:127\u2013138","journal-title":"Schizophr Res"},{"key":"1484_CR55","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1523\/JNEUROSCI.0003-07.2007","volume":"27","author":"P Rigas","year":"2007","unstructured":"Rigas P, Castro-Alamancos MA (2007) Thalamocortical UP states: differential effects of intrinsic and extrinsic cortical inputs on persistent activity. J Neurosci 27:4261\u20134272","journal-title":"J Neurosci"},{"key":"1484_CR56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-007-0758-3","volume":"193","author":"LM Rorick-Kehn","year":"2007","unstructured":"Rorick-Kehn LM, Johnson BG, Knitowski KM, Salhoff CR, Witkin JM, Perry KW, Griffey KI, Tizzano JP, Monn JA, McKinzie DL, Schoepp DD (2007) In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2\/3 receptor agonist LY404039 in animal models of psychiatric disorders. Psychopharmacology (Berl) 193:121\u2013136","journal-title":"Psychopharmacology (Berl)"},{"key":"1484_CR57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","volume":"6","author":"U Rudolph","year":"2006","unstructured":"Rudolph U, Mohler H (2006) GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 6:18\u201323","journal-title":"Curr Opin Pharmacol"},{"key":"1484_CR58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","volume":"124","author":"A Schotte","year":"1996","unstructured":"Schotte A, Janssen PFM, Gommeren W, Luyten WHML, VanGompel P, Lesage AS, DeLoore K, Leysen JE (1996) Risperiidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124:57\u201373","journal-title":"Psychopharmacology (Berl)"},{"key":"1484_CR59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(03)00547-0","volume":"346","author":"JL Scruggs","year":"2003","unstructured":"Scruggs JL, Schmidt D, Deutch AY (2003) The hallucinogen 1-[2, 5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett 346:137\u2013140","journal-title":"Neurosci Lett"},{"key":"1484_CR60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1073\/pnas.98.1.301","volume":"98","author":"JK Seamans","year":"2001","unstructured":"Seamans JK, Durstewitz D, Christie BR, Stevens CF, Sejnowski TJ (2001) Dopamine D1\/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc Natl Acad Sci U S A 98:301\u20136","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1484_CR61","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nature01616","volume":"423","author":"Y Shu","year":"2003","unstructured":"Shu Y, Hasenstaub A, McCormick DA (2003) Turning on and off recurrent balanced cortical activity. Nature 423:288\u201393","journal-title":"Nature"},{"key":"1484_CR62","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1176\/appi.ajp.161.5.882","volume":"161","author":"AK Stark","year":"2004","unstructured":"Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B (2004) Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 161:882\u2013888","journal-title":"Am J Psychiatry"},{"key":"1484_CR63","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nn1846","volume":"10","author":"S Vijayraghavan","year":"2007","unstructured":"Vijayraghavan S, Wang M, Birnbaum SG, Bruce CJ, Williams GV, Arnsten AFT (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376\u2013384","journal-title":"Nat Neurosci"},{"key":"1484_CR64","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.tins.2004.08.002","volume":"27","author":"G Winterer","year":"2004","unstructured":"Winterer G, Weinberger DR (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27:683\u2013690","journal-title":"Trends Neurosci"},{"key":"1484_CR65","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-007-0974-x","volume":"196","author":"ML Woolley","year":"2008","unstructured":"Woolley ML, Pemberton DJ, Bate S, Corti C, Jones DNC (2008) The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2\/3 agonist, LY379268, in mouse models predictive of antipsychotic activity. Psychopharmacology (Berl) 196:431\u2013440","journal-title":"Psychopharmacology (Berl)"},{"key":"1484_CR66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/mol.63.1.2","volume":"63","author":"JY Yeung","year":"2003","unstructured":"Yeung JY, Canning KJ, Zhu G, Pennefather P, MacDonald JF, Orser BA (2003) Tonically activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol Pharmacol 63:2\u20138","journal-title":"Mol Pharmacol"},{"key":"1484_CR67","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1523\/JNEUROSCI.17-21-08528.1997","volume":"17","author":"J Zahrt","year":"1997","unstructured":"Zahrt J, Taylor JR, Mathew RG, Arnsten AF (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528\u201335","journal-title":"J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1484-9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T21:34:32Z","timestamp":1738964072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-009-1484-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,25]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1007\/s00213-009-1484-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,25]]}}}